Royce & Associates LP Axsome Therapeutics, Inc. Transaction History

Royce & Associates LP

$8.75 Billion
Q1 2025

A detailed history of Royce & Associates LP transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Royce & Associates LP holds 30,257 shares of AXSM stock, worth $3.12 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

30,257

Previous 37,000 18.22%

Holding current value

$3.12 Million

Previous $3.13 Million 12.72%

% of portfolio

0.04%

Previous 0.03%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 06, 2025	SELL	$80.05 - $137.75 $539,777 - $928,848	-6,743 Reduced 18.22%	30,257 $3.53 Million
Q4 2024 Feb 10, 2025	BUY	$83.08 - $100.49 $1.2 Million - $1.46 Million	14,500 Added 64.44%	37,000 $3.13 Million
Q3 2024 Nov 06, 2024	BUY	$78.93 - $95.84 $749,835 - $910,480	9,500 Added 73.08%	22,500 $2.02 Million
Q1 2024 May 13, 2024	BUY	$69.39 - $97.64 $902,070 - $1.27 Million	13,000 New	13,000 $1.04 Million
Q3 2021 Nov 10, 2021	SELL	$19.91 - $68.26 $404,173 - $1.39 Million	-20,300 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$50.63 - $73.5 $273,402 - $396,900	-5,400 Reduced 21.01%	20,300 $1.37 Million
Q2 2020 Aug 07, 2020	SELL	$49.87 - $98.69 $718,128 - $1.42 Million	-14,400 Reduced 35.91%	25,700 $2.12 Million
Q1 2020 May 12, 2020	SELL	$41.2 - $101.31 $824,000 - $2.03 Million	-20,000 Reduced 33.28%	40,100 $2.36 Million
Q4 2019 Feb 06, 2020	SELL	$16.71 - $106.24 $745,266 - $4.74 Million	-44,600 Reduced 42.6%	60,100 $6.21 Million
Q3 2019 Nov 13, 2019	SELL	$20.24 - $29.16 $202,399 - $291,600	-10,000 Reduced 8.72%	104,700 $2.12 Million
Q2 2019 Aug 12, 2019	SELL	$13.46 - $25.75 $911,242 - $1.74 Million	-67,700 Reduced 37.12%	114,700 $2.95 Million
Q1 2019 May 09, 2019	SELL	$2.63 - $16.34 $394,500 - $2.45 Million	-150,000 Reduced 45.13%	182,400 $2.6 Million
Q3 2018 Nov 13, 2018	SELL	$2.3 - $3.55 $1.28 Million - $1.97 Million	-556,000 Reduced 62.58%	332,400 $1.15 Million
Q2 2018 Aug 09, 2018	SELL	$2.15 - $3.6 $145,340 - $243,360	-67,600 Reduced 7.07%	888,400 $2.84 Million
Q1 2018 May 14, 2018	BUY	$2.35 - $5.6 $176,250 - $420,000	75,000 Added 8.51%	956,000 $2.34 Million
Q2 2017 Aug 07, 2017	BUY	N/A	881,000	881,000 $4.85 Million

Others Institutions Holding AXSM

# of Institutions

409

Shares Held

36.6M

Call Options Held

751K

Put Options Held

568K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $4.42B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.

Account

Royce & Associates LP Axsome Therapeutics, Inc. Transaction History